Introduction
============

Neural tube defects, which are detected in about 300 000 neonates worldwide each year, are a major cause of neonatal morbidity and mortality.[@R1] They are caused by the abnormal closure of the embryonic neural tube between 22 and 28 days after conception. The resulting structural defects, which may occur anywhere along the neuraxis, often lead to the postpartum exposure of neural tissue and this, in turn, may lead to severe impairment in the child's physical and mental development.[@R2]^,^[@R3]

Classically, neural tube defects are divided into two main groups: defects affecting brain structures -- such as anencephaly and encephalocele and defects that affect the structures of the spinal cord -- such as meningocele, myelomeningocele and other forms of spina bifida.[@R4]^,^[@R5] Anencephaly -- also called exencephaly or craniorachischisis -- is defined as the complete or partial absence of the brain. This defect, which is caused by a failure of the cephalic neural tube to close,[@R6]^,^[@R7] leads to fetal deaths, stillbirths or neonatal deaths. In encephalocele, the brain and meninges herniate through a skull defect, especially in the occipital region.[@R1] Spina bifida is characterized by the failure of fusion of the vertebral arches of the spine. This defect can be covered by skin -- when it is known as spina bifida occulta -- or be associated with a cystic protrusion. In meningocele, this protrusion contains abnormal meninges and cerebrospinal fluid. In myelomeningocele, the cystic protrusion contains elements of the spinal cord and/or nerves.

Neural tube defects have been associated with both genetic factors -- e.g. simple gene mutations and chromosomal abnormalities[@R7] -- and maternal factors such as folate intake, age, ethnicity, obesity and the use of antiepileptic drugs.[@R8] If maternal intake of folic acid can be increased around the time of conception, the risk of the occurrence of neural tube defects may be reduced by 60--70%.[@R9]^--^[@R12] This preventive strategy has been adopted by 78 countries[@R13] that have mandated the addition of folic acid to flour. Such folic acid fortification has already been associated with reductions in the prevalence of neural tube defects in Canada,[@R14] Chile,[@R15] South Africa[@R16] and the United States of America (USA).[@R17]

In 2002, Brazil's Health Surveillance Agency made the fortification of wheat and maize flour with iron and folic acid mandatory in the country from June 2004 -- allowing flour producers more than a year to adapt to the new legislation[@R18] All wheat and maize flour sold in Brazil since June 2004 should contain 0.15 mg folic acid per 100 g.[@R18]

Although most studies on the prevalence of neural tube defects have been focused on live births, the prevalence of such defects among miscarriages and stillbirths may be higher than that among live births. In the United Kingdom of Great Britain and Northern Ireland, for example, such defects were detected in 2.8/1000 live births and 5.3/1000 miscarriages at eight weeks of gestation.[@R19] In Northern Ireland and south-east England neural tube defects were 7.1/1000 in live births and 10.8 /1000 in eight-week miscarriages.[@R20]

In this population-based retrospective study, we aimed to determine if the mandatory addition of folic acid to flour sold in Brazil was associated with a change in the prevalence of neural tube defects in live and stillbirths.

Methods
=======

Databases
---------

We analysed data that had been routinely collected, in central, south-eastern and southern Brazil, by the national ministry of health and recorded within either the live birth information system database -- i.e. as live births -- or the mortality information system database -- i.e. as stillbirths.

The live birth database was introduced in 1990 but has only included notification of congenital anomalies since 1999. Between 1999 and 2006, only one of the codes of the *International classification of diseases* *and related health problems*[@R21] (ICD) could be entered in this database per birth. Since 2007, however, it has been possible to enter multiple codes to cover all of the congenital anomalies present in a child.

Study design
------------

We compared the prevalence of neural tube defects among live births and stillbirths in the pre-fortification period -- i.e. 2001--2004 -- with that recorded in the post-fortification period -- i.e. 2005--2014. In our analyses, we assumed that all children born in 2004 would have been conceived before fortification became mandatory in June 2004. We therefore considered the whole year of 2004 to be pre-fortification.

Defect prevalence
-----------------

We identified as neural tube defects all anomalies coded Q00, Q01 or Q05 according to the ICD, tenth revision,[@R21] indicative of anencephaly, encephalocele and all forms of spina bifida, respectively.

We only analysed data from the states of central, south-eastern and southern Brazil in which the proportion of all births registered in either the live birth database or the mortality database was estimated to exceed 95%.[@R22]^,^[@R23] The eight states we included were the central states of Distrito Federal and Mato Grosso do Sul, the south-eastern states of Espírito Santo, Rio de Janeiro and São Paulo and the southern states of Paraná, Rio Grande do Sul and Santa Catarina.

Study variables
---------------

In our analysis we used flour fortification as the independent variable, the presence of at least one neural tube defect as the dependent variable, and maternal age, sex of the neonate or stillborn child and race of the neonate as the predictors. If no information on outcome of a birth had been recorded -- i.e. if it was possible that a neural tube defect had been detected but not recorded -- that birth was excluded from our analyses ([Fig. 1](#F1){ref-type="fig"}). Maternal age was categorized into three age groups: younger than 20, 20 to 34 and older than 34 years -- representing adolescents, young adults and older mothers, respectively. Neonatal race was recorded in the live birth database as black, brown, indigenous or white. No information on stillbirth race was available from the mortality database. The data available on maternal age and sex of the neonates or stillbirths were incomplete.

![Flowchart for the selection of birth records from the national live birth information and mortality information systems, Brazil, 2001--2014](BLT.14.151365-F1){#F1}

Data analysis
-------------

Data were exported and analysed using Epi Info version 7.0 (Centers for Disease Control and Prevention, Atlanta, USA) and Origin 6.0 (Microcal Software, Northampton, USA). The prevalence of any neural tube defect and of defect subtypes coded Q00, Q01 and Q05 were each estimated for the pre-fortification and post-fortification periods. The ratio between each pre-fortification prevalence and the corresponding post-fortification value -- and the relevant 95% confidence interval (CI) -- was calculated.

Ethics
------

The study protocol was approved by the ethics committee of the Universidade Estadual de Montes Claros, Montes Claros, Minas Gerais, Brazil.

Results
=======

We investigated the records of 19 045 161 live births from the live births database and the records of 194 858 stillbirths from the mortality database. All of the births we investigated occurred between 1 January 2001 and 31 December 2014 and together they represented 45.5% of the total (42 285 756) birth records in Brazil for that period. The 17 925 729 valid cases of live births and 194 858 stillbirths used in our analyses included 8554 and 2673 cases of neural tube defects, respectively ([Fig. 1](#F1){ref-type="fig"}).

[Table 1](#T1){ref-type="table"} summarizes the prevalence of neural tube defects recorded among all live births and stillbirths. In the pre-fortification period, the prevalence of such defects among all births -- i.e. live births and stillbirths combined -- was 0.79 per 1000 births. The corresponding post-fortification value was 30.1% lower, at 0.55 per 1000 births. Among the live births, the prevalence of neural tube defects was 22.8% lower post-fortification than pre-fortification: 0.44 versus 0.57 per 1000 live births. Among stillbirths, the prevalence was 34.0% lower post-fortification than pre-fortification: 11.70 versus 17.74 per 1000 stillbirths.

###### Prevalence of neural tube defects before and after the mandatory fortification of flours with folic acid, Brazil, 2001--2014

  Type                    No. of births investigated   No. of births with NTD   Prevalence                       
  ----------------------- ---------------------------- ------------------------ ------------ ------------------- -------
  **Live births**                                                                                                
  Pre-fortification^a^    4 938 343                    2 823                    0.57         1.29 (1.24--1.35)   −22.8
  Post-fortification^b^   12 987 386                   5 731                    0.44         1                   
  Total                   17 925 729                   8 554                    --           --                  --
  **Stillbirths**                                                                                                
  Pre-fortification^a^    65 121                       1 155                    17.74        1.52 (1.40--1.63)   −34.0
  Post-fortification^b^   129 737                      1 518                    11.70        1                   
  Total                   194 858                      2 673                    --           --                  --
  **All births**                                                                                                 
  Pre-fortification^a^    5 003 464                    3 978                    0.79         1.43 (1.38--1.50)   −30.1
  Post-fortification^b^   13 117 123                   7 249                    0.55         1                   
  Total                   18 120 587                   11 227                   --           --                  --

CI: confidence interval; NTD: neural tube defect.

^a^ The pre-fortification study period ran from 1 January 2001 to 31 December 2004 -- although fortification became mandatory in June 2014.

^b^ The post-fortification study period, which ran from 1 January 2005 to 31 December 2014, was used as the reference category in the calculation of prevalence ratios.

The prevalence of spina bifida and, particularly, anencephaly were lower post-fortification than pre-fortification among both live births and stillbirths ([Table 2](#T2){ref-type="table"}). Although we found the prevalence of encephalocele among stillbirths to be higher post-fortification than pre-fortification, this defect was only reported for 39 stillbirths.

###### Prevalence of anencephaly, encephalocele and spina bifida before and after mandatory folic acid fortification of flour, Brazil, 2001--2014

  -------------------------------------------------------------------------------------------------------------------
  Type of birth defect   Pre-fortification^a^           Post-fortification^b^   Prevalence change,\           
                                                                                %                             
  ---------------------- ---------------------- ------- ----------------------- --------------------- ------- -------
  **Live births**                                                                                             

  Anencephaly            1035                   0.21                            2063                  0.16    −24.2

  Encephalocele          388                    0.08                            871                   0.07    −14.6

  Spina bifida           1400                   0.28                            2832                  0.22    −23.1

  **Stillbirths**                                                                                             

  Anencephaly            1056                   16.22                           1322                  10.19   −37.2

  Encephalocele          39                     0.60                            95                    0.73    22.3

  Spina bifida           80                     1.23                            123                   0.95    −22.8

  **All births**                                                                                              

  Anencephaly            2091                   0.42                            3385                  0.26    −38.3

  Encephalocele          427                    0.09                            966                   0.07    −13.7

  Spina bifida           1480                   0.30                            2955                  0.23    −23.8
  -------------------------------------------------------------------------------------------------------------------

^a^ The pre-fortification study period ran from 1 January 2001 to 31 December 2004 -- although fortification became mandatory in June 2014. We analysed the data for 4 938 343 live births and 65 121 still births that occurred during this period.

^b^ The post-fortification study period ran from 1 January 2005 to 31 December 2014. We analysed the data for 12 987 386 live births and 129 737 still births that occurred during this period.

The apparent effects of maternal age and sex and race of the child on the prevalence of neural tube defects are summarized in [Table 3](#T3){ref-type="table"}. In the pre-fortification study period, compared with mothers aged 20--34 years, adolescents were 34% more likely to give birth to a still or liveborn child with a neural tube defect. In the same period, there appeared to be a 40% higher probability of a neural tube defect in a female neonate or stillbirth than in a male one. Although, pre-fortification, the prevalence of neural tube defects was higher among indigenous neonates than among black, brown or white neonates, the differences in prevalence between black, brown and indigenous neonates were not statistically significant -- probably because relatively few indigenous neonates were included in our analyses. Folic acid fortification appears to have lowered the prevalence of neural tube defects by 37.7% among the offspring of adolescent mothers and by 36.5% among female neonates and stillbirths.

###### Neonatal and maternal characteristics and the prevalence of neural tube defects before and after mandatory folic acid fortification of flour, Brazil, 2001--2014

  Characteristic                        Pre-fortification^a^           Post-fortification^b^   Prevalence change %                                                            
  ------------------------------------- ---------------------- ------- ----------------------- --------------------- -- -------------------- ------- ------ ----------------- --------
  **Maternal age, years ^c^**                                                                                                                                                 
  \< 20                                 971 805 (19.5)         915     0.94                    1.34 (1.2--1.4)          2 221 078 (17.0)     1 302   0.59   1.13 (1.1--1.2)   --37.7
  20--34^d^                             3 488 203 (70.0)       2 449   0.70                    1                        9 232 150 (70.5)     4 780   0.52   1                 --26.3
  \> 34                                 526 589 (10.6)         371     0.70                    1.00 (0.9--1.1)          1 640 707 (12.5)     938     0.57   1.10 (1.0--1.2)   --18.9
  Total                                 4 986 597 (100.0)      --      --                      --                       13 093 935 (100.0)   --      --     --                --
  **Sex of neonate or stillbirth^e^**                                                                                                                                         
  Female                                2 437 225 (48.8)       2 264   0.93                    1.44 (1.3--1.5)          6 393 203 (48.8)     3 769   0.59   1.18 (1.1--1.2)   --36.5
  Male^f^                               2 560 657 (51.2)       1 656   0.65                    1                        6 718 656 (51.2)     3 368   0.50   1                 --22.5
  **Total**                             4 997 882 (100.0)      --      --                      --                       13 111 859 (100.0)   --      --     --                --
  **Race of neonate**^g^                                                                                                                                                      
  White                                 3 505 035 (77.4)       1 983   0.57                    1.1 (1.0--1.2)           8 730 308 (69.4)     3 895   0.45   1.05 (1.0--1.1)   --21.1
  Brown ^h^                             880 425 (19.5)         439     0.50                    1                        3 347 507 (26.6)     1 422   0.42   1                 --14.8
  Black                                 122 622 (2.7)          73      0.60                    1.2 (0.9--1.5)           454 023 (3.6)        204     0.45   1.06 (0.8--1.3)   --24.5
  Indigenous                            15 930 (0.3)           13      0.82                    1.6 (0.9--2.8)           41 980 (0.3)         21      0.50   1.18 (0.8--1.8)   --38.7
  **Total**                             4 524 012 (100.0)      --      --                      --                       12 573 818 (100.0)   --      --     --                --

CI: confidence interval; NTD: neural tube defects.

^a^ The pre-fortification study period ran from 1 January 2001 to 31 December 2004 -- although fortification became mandatory in June 2014.

^b^ The post-fortification study period ran from 1 January 2005 to 31 December 2014.

^c^ Maternal age was missing in 0.22% of the records.

^d^ Used as the reference category in the calculation of prevalence ratios for maternal age.

^e^ Sex of neonate or stillbirth was missing in 0.06% of the records.

^f^ Used as the reference category in the calculation of prevalence ratios for sex of neonate or stillbirth.

^g^ As no data on race were available for stillbirths, the data reported for race refer only to live births.

^h^ Used as the reference category in the calculation of prevalence ratios for race of neonate.

Although the pre-fortification and post-fortification study subjects were similar in terms of the sex distribution of the neonates or stillbirths, they differed slightly in terms of maternal age and neonatal race ([Table 3](#T3){ref-type="table"}).

Discussion
==========

Our finding of a decreased prevalence of neural tube defects after mandatory fortification of flour with folic acid confirms observations made in two previous Brazilian studies.[@R24]^,^[@R25] One study investigated births in 19 hospitals that together represented 1% of all births in Brazil, and found a reduction in prevalence of 22.1% -- from 1.04/1000 births pre-fortification to 0.81/1000 births post-fortification.[@R24] The other study compared the prevalence of spina bifida in live births for one year pre-fortification and one year post-fortification, and reported a 39.1% reduction; 0.23/1000 to 0.14/1000 births.[@R25] This study, however, included data from states where a substantial proportion of births are not recorded in the live birth database.[@R25] Our study covers a longer period, a higher proportion of Brazilian births and all common forms of neural tube defects.

The reduction that we observed in the prevalence of neural tube defects in Brazil is higher than the corresponding reduction reported in the USA (19%),[@R17] very similar to the reduction observed in South Africa (30.5%)[@R16] and lower than the reductions reported in Chile (40%),[@R15] Canada (46%)[@R14] and -- for anencephaly and spina bifida only -- Argentina (58--60%).[@R24] A meta-analysis of eight population-based studies on the fortification of flour or other foodstuffs with folic acid estimated the mean reduction in the prevalence of neural tube defects to be 46%.[@R11] Although 78 countries have now made fortification of some foodstuffs with folic acid mandatory,[@R13] only five have evaluated the effectiveness of such an intervention in the improvement of health outcomes.[@R11]

In our study, anencephaly was the most common type of neural tube defect, followed by spina bifida and then encephalocele. Although spina bifida has often been reported as the most common form of defect -- followed by anencephaly and then encephalocele.[@R24] Earlier reports on this topic have focused on live births whereas we investigated neural tube defects in both live births and stillbirths. It appears that, in Brazil at least, spina bifida occurs more frequently in stillbirths than in live births. The use of data from live births alone may lead to underestimates in the overall prevalence of neural tube defects.[@R19]^,^[@R20]

As seen in this and other studies,[@R14]^,^[@R26]^--^[@R28] neural tube defects occur more often among female neonates and stillbirths than among males. Although the link between such defects and sex is probably complex, a female fetus requires more human chorionic gonadotropin than a male fetus and deficiencies in this hormone can increase the risk of neural tube defects. The neural tube closes in the first four weeks of embryonic development -- i.e. well before the concentration of human chorionic gonadotropin in the fetus peaks on days 40--50 post-fertilization.[@R29]^,^[@R30]

In the present study, the prevalence of neural tube defects was found to be highest among indigenous neonates, closely followed by black neonates -- although it should be noted that there were relatively few birth or death records of indigenous neonates. A study in Canada also found that the risk of neural tube defects was highest among indigenous neonates.[@R31] Researchers in the USA found that the risk of neural tube defects in pregnancy was twice as high for women of Mexican descent than for white women.[@R32]

The effect of maternal age on the risk of neural tube defects is generally considered to be small. When any such association is observed, the prevalence of neural tube defects tends to be relatively high among those born to mothers in the youngest and oldest age groups.[@R33] It is possible that the diets of adolescent mothers fail to satisfy the combined nutrient requirements for the growth of both the mother and her fetus. Another possibility is that, compared with older women, adolescent women are less likely to take supplements that contain folic acid.[@R34] It remains unclear why older mothers might be at relatively high risk of giving birth to a child with a neural tube defect.

The public reporting of health data allows health planners to take evidence-informed policy decisions and helps foster a culture of accountability, transparency and efficiency.[@R35]^,^[@R36] The relative completeness and reliability of Brazil's live birth database and mortality information database were essential to the success of our study. Although the public reporting of demographic and health-care data in Brazil began in the 1970s, it was only after the implementation of the national public health system in the mid-1980s that the Brazilian Ministry of Health and other investigators concentrated efforts to guarantee the quality of the data being collected. There has been much evidence of the success of these efforts,[@R35]^,^[@R37]^--^[@R39] including the results of a case--control study[@R40] and active searches for unreported births and deaths.[@R41]^,^[@R42] In 2010, the United Nations Children's Fund acknowledged the political commitment to improving the health information systems in Brazil, especially those recording data on births and infant deaths.[@R43] Brazil's health information systems are now in line with the World Health Organization's push towards evidence-informed policy.[@R44]

A possible source of bias in this study is the termination of pregnancy when the fetus is found to be anencephalic. Although abortion is illegal in Brazil, individual court rulings may override the law. However, there is so much bureaucracy involved in such cases that few abortions are permitted. We were unable to investigate -- or control for -- the effects of birth order, which is not recorded in either of the information systems we used. We assumed that children born in the second trimester of 2004 would not have benefited from maternal consumption of flour fortified with folic acid. It remains possible that some of these children did benefit but this would indicate that the benefits of fortification were even greater than those we presented.

Conclusion
==========

Our results show that the introduction of the mandatory fortification of flour with folic acid in Brazil was followed by a significant reduction in the incidence of neural tube defects in the centre, south-east and south of the country.
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